Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
OHSU Knight Cancer Institute
Eastern Cooperative Oncology Group
Children's Oncology Group
Children's Hospital of Philadelphia
Children's Oncology Group
Dana-Farber Cancer Institute
City of Hope Medical Center
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
NYU Langone Health
Dana-Farber Cancer Institute
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Mayo Clinic